About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Symptom Collection of Lung Cancer Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT03384680

Symptom Collection of Lung Cancer Patients

This study is conducted to collect the symptoms of lung cancer patients and to observe the relationship with proteomics.

Lead sponsor: Seong-Gyu Ko•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Chunhoo Cheon

CONTACT

02-961-9278 pm.thehoo@gmail.com

Sponsors

Lead Sponsor

Seong-Gyu Ko

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult over 18 years old
•Patients are scheduled for surgery with lung cancer diagnosis.
•ECOG status score 0 to 2
•Individual who can read and understand Korean
•Participant is willing and able to give informed consent for participation in the study

Exclusion Criteria

•Patient who was diagnosed with lung cancer in the past.
•Individuals who are judged inappropriate for the study

Related studies

RECRUITINGPhase 3

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

NCT06312137 · Non Small Cell Lung Cancer

RECRUITINGPhase 3

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

NCT07005128 · Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer

RECRUITINGPhase 2

A Phase II Clinical Trial of SHR-1826 for Non-Small Cell Lung Cancer

NCT07489716 · Non-Small Cell Lung Cancer

RECRUITINGPhase 2

A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer

NCT07444437 · Non-Small Cell Lung Cancer

RECRUITINGPhase 2

A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

NCT07308106 · Non-small Lung Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2018Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment100

Start dateSep 2015

Last updatedJan 9, 2018

Condition

Locations shown

Korea University Guro Hospital

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions